Skip to main content
OpenTrials

Clinical trial condition

Hepatitis

Explore clinical trials studying Hepatitis. Study availability and eligibility vary by location and protocol.

2,969 public trials 189 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis trial results

Completed

Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection

NCT00513461

Conditions
Adenocarcinoma, Adult Primary Liver Cancer, Blood-Borne Infections, +19 more
Locations
  • University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Veterans Administration Long Beach Medical Center Long Beach, California, United States
  • Veterans Administration Los Angeles Healthcare System Los Angeles, California, United States
  • Chao Family Comprehensive Cancer Center Orange, California, United States
View Trial Details
Completed

Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age

NCT00197002

Conditions
Digestive System Diseases, Enterovirus Infections, Hepatitis, +7 more
Locations
  • GSK Investigational Site Centennial, Colorado, United States
  • GSK Investigational Site Bardstown, Kentucky, United States
  • GSK Investigational Site Louisville, Kentucky, United States
  • GSK Investigational Site Boston, Massachusetts, United States
View all 18 locations
View Trial Details
Completed

Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) Assay

NCT02167113

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Banner Health Good Samaritan Phoenix, Arizona, United States
  • Dignity Health - St. Joseph's Hospital Phoenix, Arizona, United States
  • Advanced Rx Clinical Research Garden Grove, California, United States
  • High Desert Gastroenterology Lancaster, California, United States
View all 90 locations
View Trial Details
Completed

Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children

NCT00197015

Conditions
Digestive System Diseases, Enterovirus Infections, Hepatitis, +7 more
Locations
  • GSK Investigational Site Cabot, Arkansas, United States
  • GSK Investigational Site Jonesboro, Arkansas, United States
  • GSK Investigational Site North Little Rock, Arkansas, United States
  • GSK Investigational Site Huntington Beach, California, United States
View all 42 locations
View Trial Details
Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

NCT01627340

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +14 more
Locations
  • GSK Investigational Site Huntsville, Alabama, United States
  • GSK Investigational Site Stockbridge, Georgia, United States
  • GSK Investigational Site Boise, Idaho, United States
  • GSK Investigational Site Mishawaka, Indiana, United States
View all 22 locations
View Trial Details
Completed

Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection

NCT00388674

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Scti Research Foundation Coronado, California, United States
  • Cedars-Sinai Comprehensive Transplant Center Los Angeles, California, United States
  • Kaiser Permanente Medical Center San Francisco, California, United States
  • University Of Connecticut Health Center Farmington, Connecticut, United States
View all 290 locations
View Trial Details
Completed

Optimized Treatment and Regression of HBV-induced Early Cirrhosis

NCT01938820

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
Locations
  • Beijing Ditan Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • 302 Military Hospital Of China Beijing, Beijing Municipality, China
View all 21 locations
View Trial Details
Completed

Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis

NCT01943617

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
Locations
  • Beijing Ditan Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • 302 Military Hospital Of China Beijing, Beijing Municipality, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
View all 21 locations
View Trial Details

Related conditions